Brachytherapy for meningiomas. Review uri icon

Overview

abstract

  • Interstitial intracranial radiotherapy implants, or brachytherapy, is an adjuvant option for treatment of recurrent high-grade meningiomas after resection. The implants are placed in the resection cavity following tumor resection. The most commonly used isotope is Iodine-125 (I-125). While there are no controlled studies comparing treatment of meningiomas with or without brachytherapy, several case series report good long-term survival, suggesting that this may be a useful adjuvant for recurrent high-grade tumors. Complications can occur including radiation necrosis, impaired wound healing, hydrocephalus and infection. In the future, new isotopes are being explored that may have fewer complications and better safety profiles.

publication date

  • January 1, 2020

Research

keywords

  • Brachytherapy
  • Iodine Radioisotopes
  • Meningeal Neoplasms
  • Meningioma

Identity

Scopus Document Identifier

  • 85087053982

Digital Object Identifier (DOI)

  • 10.1016/B978-0-12-822198-3.00049-5

PubMed ID

  • 32586503

Additional Document Info

volume

  • 170